symptom experience and self-management after haematopoietic stem cell transplantation

Conditions: Hematologic Neoplasms

Summary: in the study provivo, a patient reported outcome instrument consisting of items from the pro-ctcae item bank measuring symptom experience of long-term survivors after allogeneic hematopoietic stem cell transplantation (sct) will be developed. the instrument development is based on cognitive patient interviews, a survey of hematology experts and a literature review. in a subsequent cross-sectional study phase, the instrument will be validated in a sample of 300 allogeneic stem cell recipients and by the use of additional self report instruments it will be possible to explore how subjective symptom experience, problems in self-management and presence of late effects are connected.

long-term survivors after allogeneic sct are presumably at a life-long increased risk for developing various adverse side effects; also termed 'late effects'. late effects may appear months or years after treatment has ended, can persist chronically and may be experienced as rather distressing and burdensome. since most late effects are only experienced subjectively in the form of physical and mental symptoms and are seldom captured during objective clinician-based evaluations, using self-report instruments is important for the early detection, management and alleviation of these symptoms. the collection of self-report data in studies and clinical practice is strongly recommended by the national cancer institute (nci): they developed a patient-reported outcomes bank based on the well established common terminology criteria for adverse events (pro-ctcae). besides managing symptoms associated with late-effects, patients with sct are also requested to manage their emotions associated with having a chronic illness, their new life roles in order to have a meaningful, fulfilling life, and their medical regimen, in view of taking medications, smoking cessation, regularly exercising and monitoring for signs of infection. however, evidence investigating the prevalence of problems related to these complex set of self-management tasks is scarce. aims: * to translate the pro-ctcae items into german in a culturally-sensitive way and to develop the content of a self-report instrument measuring symptom experience after allogeneic sct * to validate the newly developed scale and assess its psychometric properties * to examine self reported symptom experience and objective measured late effects in 300 adult survivors ≥ 1 year after sct * to describe self-management behaviours in 300 adult survivors ≥ 1 year after sct * to assess the relationship between symptom experience and objective burden of late effects, survivors' perception of late effects and self-management in view of managing emotions, managing new life roles and managing medical and health tasks in 300 adult survivors ≥ 1 year after allogeneic sct

Eligibility criteria:
inclusion criteria: * having received allogeneic sct for haematological disease * ≥ 1 year of follow-up experience after treatment * ability to understand and read german and having signed the written informed consent exclusion criteria: * patients with psychiatric illness that in the opinion of physicians prevent them from participating * visual and/or hearing impairment which hinders participation in an interview/fill-out a questionnaire * being illiterate * actual acute care hospitalization stay at interview date * terminal illness

Keywords: stem cell transplantation symptom experience late effects self-management